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Abstract: The “calibrated fMRI” technique requires a hypercapnia calibration experiment in order to estimate the factor 
“M”. It is desirable to be able to obtain the M value without the need of a gas challenge calibration. According to the 
analytical expression of M, it is a function of several baseline physiologic parameters, such as baseline venous 
oxygenation and CBF, both of which have recently been shown to be significant modulators of fMRI signal. Here we 
studied the relationship among hypercapnia-calibrated M, baseline venous oxygenation and CBF, and assessed the 
possibility of estimating M from the baseline physiologic parameters. It was found that baseline venous oxygenation and 
CBF are highly correlated (R
2=0.77, P<0.0001) across subjects. However, the hypercapnia-calibrated M was not 
correlated with baseline venous oxygenation or CBF. The hypercapnia-calibrated M was not correlated with an estimation 
of M based on analytical expression either. The lack of correlation may be explained by the counteracting effect of venous 
oxygenation and CBF on the M factor, such that the actual M value of an individual may be mostly dependent on other 
parameters such as hematocrit. Potential biases in hypercapnia-based M estimation were also discussed in the context of 
possible reduction of CMRO2 during hypercapnia. 
Keywords: Calibrated fMRI, venous oxygenation, cerebral blood flow, cerebral metabolic rate of oxygen, brain. 
INTRODUCTION 
  Blood-Oxygenation-Level-Dependent (BOLD) fMRI is 
based on MRI signal changes associated with indirect effects 
of neural activation [1]. Increases in neural activity result in 
an increase in brain’s metabolism [2], which in turn activates 
neurovascular coupling pathways to cause vasodilation and 
augmented cerebral blood flow (CBF) and cerebral blood 
volume (CBV) [3]. The amplitude and spatial extent of CBF 
increase are often greater than that of metabolism [4]. 
Consequently, the activated brain regions are “over-
perfused” and the blood oxygenation level is actually higher 
than that during baseline state. This difference in blood 
oxygenation level can be related to MR signal intensity via 
the paramagnetic property of the deoxyhemoglobin 
molecules [5]. This fortuitous phenomenon is utilized for 
functional brain mapping. In the past two decades, much 
effort has been devoted to understanding the relationship 
between neural activity and BOLD signal with the hope of 
using BOLD signal to calculate back the neural signal. 
However, with a few exceptions under special circumstances 
[6,7], it has not been possible to establish a general 
relationship or model between neural activity and fMRI 
signal, due to the exceptional complexity of neural network 
and computation. On the other hand, the relationship among 
MR signal, hemodynamic response, and metabolism has 
been studied with more success [5,8-13]. To this end, it has  
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been suggested that one can estimate the activation-induced 
changes in oxygen metabolism, often denoted by the index 
cerebral metabolic rate of oxygen (CMRO2), from 
experimental measures of BOLD signal, CBF and CBV in 
conjunction with theoretical models of BOLD effect [9-
11,13]. Although oxygen metabolism still does not reflect 
the exact change in neural activity, it is nonetheless 
considered a better index in terms of signaling brain function 
and neural processing [2]. 
  At present, the most widely used quantitative BOLD 
technique is called “calibrated fMRI” [9,10]. This method 
uses a simplified BOLD model which only requires two 
experimental measures, BOLD signal and CBF changes, in 
order to calculate the relative changes in CMRO2. However, 
as a result of the model simplification, the calibrated fMRI 
technique uses a number of assumptions and also requires 
the knowledge of a calibration factor, “M”, that needs to be 
determined for each individual if not for each voxel. M is 
typically estimated by performing an additional calibration 
experiment while having the subject breath 5% CO2 [10] or 
100% O2 [14]. It would be desirable to be able to obtain the 
M value without the need of a gas-challenge calibration, 
which would make the technique more feasible for 
neuroscience and clinical studies. According to the analytical 
expression of M, it is a function of two baseline physiologic 
parameters, baseline CBF and baseline venous oxygenation 
(Yv). Interestingly, both parameters have recently been 
shown to be significant modulators of fMRI signal and can 
explain a large fraction of intersubject variations in BOLD 
signal amplitude [15,16].  Relationship Between M and fMRI Modulators  The Open Neuroimaging Journal, 2011, Volume 5    113 
  Here we measured baseline CBF using phase-contrast 
(PC) velocity MRI [17] and baseline venous oxygenation 
using T2-Relaxation-Under-Spin-Tagging (TRUST) MRI 
[18] in seventeen healthy subjects. M values were 
determined using hypercapnia calibration experiments while 
simultaneously acquiring BOLD and Arterial-Spin-Labeling 
(ASL) images [10]. Possible correlation between M and the 
baseline measures was assessed. The relationship between 
M, baseline CBF and baseline Yv was also investigated in the 
context of biophysical models.  
MATERIALS AND METHODS 
Theory: 
  Based on the calibrated fMRI model developed by Davis 














]         (1) 
in which the calibration factor  
M = TE  A  CBV0  [Hct  (1  Yv,0)]

              (2) 
where TE and A are constants related to magnetic field 
strength and imaging parameters; CBV0, CBF0 and Yv,0 are 
the baseline CBV, CBF and Yv, respectively; Hct is the 
hematocrit;  is the Grubb’s coefficient between CBV and 
CBF [19];  is a coefficient related to vascular geometry 
[20]. From Eq. (1), it can be seen that relative changes in 
BOLD signal, CMRO2 and CBF are closely related and 
experimental measurement of two of them can yield the 
estimation of the third parameter, provided that the M factor 
is known. The physiologic meaning of the M factor is well 
known: it is the maximum BOLD signal one can get from a 
voxel when (hypothetically) all deoxyhemoglobin molecules 
are displaced. Therefore, the M factor is related to how much 
deoxyhemoglobin the voxel contains at baseline. This can 
been from Eq. (2) which shows that the value of M is greater 
when the voxel contains more blood and the blood has 
higher hematocrit and less oxygen.  
  At present, the value of the M factor is determined by a 
separation calibration experiment performed on the same 
individual with the same slice position [10,14]. Based on Eq. 
(1), one can readily appreciate that, if we apply a physiologic 
manipulation that changes BOLD and CBF but not CMRO2, 
the CMRO2 term in Eq. (1) will vanish. Then if we measure 
BOLD and CBF changes during the manipulation, the M 
factor can be calculated. To date, virtually all calibrated 
fMRI studies have used this method to estimate M with the 
majority using hypercapnia [9,21] and a few using hyperoxia 
challenges [14]. 
  Given that the M factor is an index of the baseline 
physiologic state, specifically related to baseline CBV and 
baseline venous oxygenation, and is not intrinsically linked 
to any physiologic challenge, we hypothesized that, if we 
could use non-invasive experimental methods to measure the 
baseline parameters on a subject-by-subject basis, we could 
then estimate the M factor without the need of challenge 
experiment. In Eq. (2), TE and A are related to imaging 
parameters and are not subject dependent. Hematocrit may 
vary from 0.35 to 0.50 for normal adults. However, it is not 
feasible to measure Hct non-invasively, thus its effect on M 
was not assessed. Yv,0 was determined using a recently 
developed TRUST MRI technique [18]. The measurement of 
CBV0 requires the use of MRI contrast agent and is again 
invasive [22]. Thus we instead measured CBF0 using phase-
contrast velocity MRI [17] and converted it to CBV0 using 
the Grubb’s equation [19]. The relationship between the M 
factor and the baseline physiologic parameters then become: 
M = TE  A  CBF0

 [Hct  (1  Yv,0)]

              (3) 
  All parameter values discussed in this study are for the 
whole brain. 
Experiments 
  The experiments were performed on a 3T MRI system 
(Philips Medical Systems, Best, The Netherlands). The 
protocol was approved by UT Southwestern Medical 
Center’s Institutional Review Board and informed written 
consent was obtained from each participant. The body coil 
was used for RF transmission and an eight-channel 
sensitivity encoding (SENSE) head coil was used for 
receiving. Foam padding was used to stabilize the head and 
minimize motion. A total of eleven healthy subjects (5 men 
and 6 women, 28 ± 3 years of age) participated in this study.  
 Fig.  (1A) shows the experiment design of the study. 
Global baseline venous oxygenation was measured using a 
TRUST MRI technique [18]. The TRUST technique uses 
spin labeling principle to isolate pure venous blood signal, 
then determines the T2 of the blood, from which the 
oxygenation level was estimated. Fig. (1B) shows the slice 
position of TRUST MRI. In this study, the experiments were 
performed at the level of sagittal sinus (SS), essentially 
measuring the oxygenation level of venous blood that is 
drained by SS. SS was chosen over the jugular vein because 
imaging at the SS is more robust and shorter in duration 
(critical for maintaining constant physiology during the 
measurement) [23]. Previous studies have shown that venous 
oxygenation is spatially homogeneous at baseline [24,25], 
thus Yv,0 measured at the SS should presumably reflect that 
of the whole brain. The imaging parameters for TRUST MRI 
were: single-shot EPI, axial plane, voxel size = 
3.44x3.44x5mm
3, field of view (FOV) = 220x220x5mm
3, 
repetition time (TR) = 8000ms, echo time (TE) = 7ms, 
inversion time (TI) = 1200ms, tagging slab thickness = 
80mm, gap between imaging slab and tagging slab = 20mm, 
four different T2-weightings with eTE of 0ms, 40ms, 80ms 
and 160ms, corresponding to 0, 4, 8 and 16 refocusing pulses 
in the T2-preparation ( 
CPMG =10 ms ). For each eTE, four 
pairs of tag and control images were acquired to improve 
signal-to-noise ratio (SNR). The total scan time of TRUST 
MRI is 4 minutes and 16 seconds. 
  Global baseline CBF was measured with the phase-
contrast velocity technique [17]. The slice again was 
positioned at the level of sagittal sinus. Note that the blood 
flow in the sagittal sinus is about 50% of that of the whole 
brain. But this scaling factor can be combined with the 
constant A and should not affect the relationship between 
baseline CBF, baseline venous oxygenation and M. The 114    The Open Neuroimaging Journal, 2011, Volume 5  Lu et al. 
following parameters were used: single slice, voxel size = 
0.45x0.45x5 mm
3, FOV = 230x230x5 mm
3, maximum 
velocity encoding = 80 cm/s. The scan duration was 30 
seconds. 
  For comparison, a conventional hypercapnia-calibration 
experiment was performed. A two-way non-rebreathing 
valve/mouthpiece combination (Hans Rudolph, 2600 series, 
Shawnee, KS) was used to deliver a 5% CO2 solution 
(balanced with 21% O2 and 74% N2; contained in a Douglas 
bag) for hypercapnic induction. A capnograph device 
(Capnogard, Model 1265, Novametrix Medical Systems, 
CT) was used to monitor end-tidal CO2, and a pulse oximeter 
(MEDRAD, Pittsburgh, PA) was used to monitor breathing 
rate, heart rate, and arterial oxygenation saturation. Values 
from both devices were recorded on a Lenovo tablet PC 
running the Microsoft Vista operating system and using 
HyperTerminal (Private Edition, Version 6.3, by Hilgraeve, 
Monroe, MI) for data collection. For imaging acquisition, 
simultaneous BOLD and ASL acquisitions were used to 
obtain BOLD and CBF changes concomitantly. The 
sequence was a pseudo-CASL method [26,27] with two echo 
times (TE) at 11 and 30ms, respectively. The subjects 
breathed room air for 4 minutes and 5% CO2 for 6 minutes. 
The other imaging parameters for PCASL were: Flip 
angle=90°, 16 slices, thickness 5 mm, orientation transverse, 
TR=4 s, 150 volumes.  
Data Processing and Analysis 
  The data processing procedures for TRUST MRI and 
phase contrast MRI were based on an algorithm described 
previously [18,23]. Briefly, after pair-wise subtraction 
between control and tag images, a preliminary region-of-
interest (ROI) was manually drawn to include the sagittal 
sinus. This ROI tended to have about 30-50 voxels which 
include the vein as well as some surrounding tissue. To 
further define the venous voxels, the voxels with highest 
blood signals (according to the difference signals) in the ROI 
were chosen as the final mask for spatial averaging. For the 
purpose of standardizing protocol, we use 4 peak voxels in 
this study, although we have tested the effect of voxel 
number and found that the results are relatively insensitive to 
the voxel number [18]. The venous blood signals were fitted 
to a mono-exponential function to obtain T2. The T2 was in 
turn converted to Yv via a calibration plot [18] obtained by in 
vitro bovine blood experiments under controlled 
oxygenation, temperature and hematocrit conditions [28,29]. 
  For phase-contrast MRI data, a preliminary ROI was 
drawn on the sagittal sinus based on the magnitude image 
[23]. A signal intensity threshold was then applied to the 
magnitude image to obtain the final vessel mask. The 
threshold was set to be 2 times the background noise. The 
final mask was applied to the phase image (velocity map) 
and the integration of the map (i.e. velocity x area) yielded 
cerebral blood flow in the unit of ml/min. We have tested the 
inter-rater variability of this processing procedure and found 
that the results are highly consistent across raters. 
  For the hypercapnia-calibration data, the two echoes 
were separately saved as different files. Motion correction 
was performed for each file (SPM, Wellcome Department of 
Imaging Neuroscience, University College London, London, 
UK). In-house MATLAB scripts were used to conduct 
 
 
Fig. (1). Experimental protocol for the study. A) Experiment design. Before the subject enters the magnet, breathing apparatus (including 
mouth piece, nose clip, end-tidal CO2 sampling tube) was attached to the subject. Following survey and reference scans, TRUST MRI was 
performed to measure baseline venous oxygenation. Phase-contrast velocity MRI was used to measure CBF. Finally, pseudo-continuous ASL 
sequence was used with two echoes to simultaneously measure BOLD and CBF signal changes during hypercapnia challenge. During the 
ASL scan, the subject breathed four minutes of room-air. Then the gas valve was switched to CO2 gas mixture and the scan continued for 
another six minutes. The first two minutes after the switching was considered transition time and the data acquired were not used in the 
analysis. B) Position of imaging slice and labeling slab for TRUST MRI. The labeling slab is above the imaging slice for venous blood 
labeling. A relatively large gap (2 cm) between the imaging slice and labeling slab was used to minimize the saturation of labeling pulse on 
the imaging slice. This gap is not expected to affect the venous blood signal intensity as the flow velocity in these veins is relatively high 
(~16 cm/s) and the blood in the gap would have flown out of the imaging slice by the time of acquisition. Relationship Between M and fMRI Modulators  The Open Neuroimaging Journal, 2011, Volume 5    115 
surrounding subtraction of the control and label images in 
the first echo and to calculate the CBF weighted images. An 
ROI containing the whole brain tissue was manually 
delineated on the BOLD images (the second echo). The ROI 
was applied to the CBF weighted images to obtain a time 
course of CBF, from which CBF/CBF0 between 
normocapnia (volumes 1 to 60) and hypercapnia (volumes 
91 to 150) were quantified. Volumes 61-90 (2 minutes 
immediately following the gas switch) were considered 
transition time between the two states and were not included 
in the analysis. Similar methods were used to obtain the 
BOLD signal change, S/SBOLD. The M factor was then 
calculated using the relationship described in the Theory 
section. We assumed alpha to equal 0.38 (based on Grubb et 
al., 1974) and beta to equal 1.33 (based on reports in Lu and 
van Zijl, 2005 that at 3T the relative contribution of 
extravascular and intravascular BOLD effect is 2/3 and 1/3, 
respectively [30]). 
  Pearson correlation was calculated for each pair of the 
three parameters, baseline Yv, baseline CBF, and M. Using 
Eq. (2), baseline Yv and baseline CBF were also combined to 
provide a relative estimate of M and its correlation with the 
hypercapnia-calibrated M was assessed. We further 
conducted model fitting with baseline Yv, baseline CBF, and 
M as known variables and A,  and  as fitting parameters. 
Using this set of fitted parameters, the values of M were 
calculated again and its correlation with hypercapnia 
calibrated M was studied. 
RESULTS 
 Fig.  (2A) shows a representative plot of venous signal 
(control-label in the sagittal sinus) as a function of effective 
TE from the TRUST data. It can be seen that the MR signal 
decays with TE and yields a good fitting to a mono-
exponential model. For the entire group of subjects, the 
venous blood T2 (at  CPMG=10 ms) was found to be 
57.7±16.0 ms (N=11, mean±STD). Using an in vitro 
calibration plot, these values were converted to baseline 
venous oxygenation values of 61.6±9.4%. Figs. (2B-E) show 
representative images from phase-contrast velocity MRI. 
The outflow of blood in the venous vessels can be clearly 
seen in the velocity map (Fig. 2E). Baseline CBF in the 
sagittal sinus was found to be 317.1±85.8 ml/min. Fig. (3) 
shows a scatter plot between baseline venous oxygenation 
and baseline CBF across subjects. It can be seen that there is 
a significant correlation (P=0.0002) between these two 
physiologic parameters. Individuals with higher blood flow 
tend to have higher oxygenation in the venous vessels. Thus 
the baseline physiologic parameters in Eq. (3) are themselves 
inter-dependent. 
  The hypercapnia challenge increased the CBF and BOLD 
signals by 60.7±27.5% and 2.52±1.06%, respectively. Using 
 
Fig. (2). Representative data for TRUST MRI and phase-contrast MRI. A) TRUST MRI signal, i.e. control-label, in the sagittal sinus as a 
function of effective TE. The symbol shows the experimental results. The solid curve shows the fitting of the data to a mono-exponential 
function. The time constant of the decay, i.e. T2 relaxation time of the blood, is also shown. B) Anatomical image from the phase-contrast 
scan. C) Posterior portion of the anatomic image highlighted by the orange box. D) Magnitude image of the phase-contrast scan showing 
large vessels as bright signals. The two bright regions indicate the superior sagittal sinus and the straight sinus, respectively. E) Velocity 
map. The flow in the veins is shown in dark color because the flow direction is downwards.  116    The Open Neuroimaging Journal, 2011, Volume 5  Lu et al. 
Eq. (1), the M factor was found to be 0.074±0.019 (unitless), 
in good agreement with literature values at this field strength 
[21,31]. A spatial map of hypercapnia-based M is shown in 
Fig. (4). No previous studies have shown a map of the M 
factor. Note that the image appears blurred because the 
CBF/BOLD data were spatially smoothed (FWHM=12 mm) 
in order to improve SNR for reliable calculation. Even with 
smoothing, a few isolated spots (arrows in Fig. 4) still 
showed unusually bright or dark intensities due to erroneous 
BOLD or CBF signals in the presence of noise. Nonetheless, 
the majority of the voxels has reasonable M values and there 
is a clear contrast between gray and white matter, with gray 
matter manifesting a greater M value due to the presence of 
more vasculature.  
 
  Next, we studied the relationship between M and baseline 
venous oxygenation/baseline CBF. We found that the M 
factor is not correlated with either baseline venous 
oxygenation or baseline CBF (Fig. 5A and B). Furthermore, 
when using Eq. (3) to estimate the M values from baseline 
venous oxygenation and CBF (assuming =0.38,  =1.33, 
Hct=0.4,  TE  A = 0.1), the estimated M and hypercapnia-
based M were not correlated either (Fig. 5C). We then 
hypothesized that the lack of correlation between the 
hypercapnia-calibrated M and the baseline-parameter-
estimated M may be attributed to incorrectly assumed values 
in ,  and A. Thus we conducted model fitting (Eq. (3)) 
with baseline venous oxygenation and CBF as independent 
variables and hypercapnia-calibrated M as dependent 
variable. The fitted ,   and A values were then used to 
calculate the estimated M. These M values were again not 
correlated with the hypercapnia-based M.  
DISCUSSION 
  In calibrated fMRI, the M factor is typically determined 
using hypercapnia challenge experiments [9,10,13,21,32,33]. 
On the other hand, the analytical expression of M suggests 
that it is related to baseline physiologic parameters of the 
individual. In the present study, we used non-invasive MRI 
methods to determine baseline venous oxygenation and 
baseline CBF, and aimed to estimate the M factor from these 
two measures. However, despite strong correlation among 
baseline venous oxygenation and CBF themselves, no 
apparent relationship was identified between them and the 
hypercapnia-calibrated M values. This was the case for the 
analysis of separate CBF or venous oxygenation or their 
combination according to the analytical expression. 
  The exact reason for a lack of correlation between 
hypercapnia-based M and baseline parameters is not clear. 
The theoretical framework described in Eqs. (1-2) is based 
on well-established biophysical and physiologic principles of 
MR signal mechanism [20]. Thus the definition and 
analytical expression of the M factor is thought to be valid. 
However, both experimental methods used to determine M 
may contain potential sources of error. The CBF/Yv-based 
method have primarily focused on the influence of these two 
variables on M, but did not account for intersubject 
variations in other factors listed in Eq. (3), such as , , and 
 
Fig. (3). Scatter plot between baseline venous oxygenation and 
baseline CBF across subjects (N=11). Each symbol represents data 
from one subject. 
 
Fig. (4). A representative map of the M factor. Eight slices are show. The data of BOLD and CBF were first smoothed before being used to 
calculate the M factor on a voxel-by-voxel basis. Arrows indicate regions where the estimated M values were clearly out of the reasonable 
range. This may be because of errors in the CBF and BOLD signals (e.g. decreased CBF and increased BOLD signal) which resulted in poor 
model fitting. Relationship Between M and fMRI Modulators  The Open Neuroimaging Journal, 2011, Volume 5    117 
Hct. Therefore, the estimated M may be inaccurate due to 
one or several of the following reasons: 1) the effect of 
hematocrit was not accounted for and may be a significant 
factor in determining M; 2) the coefficient  is associated 
with vascular geometry and the relative contributions of 
intra- and extra-vascular contributions to BOLD effect, and 
could be region and subject specific; 3) we measured CBF 
instead of CBV (due to the need of contrast agent injection) 
and used Grubb’s equation to estimate CBV, but the 
relationship between CBF and CBV may be slightly different 
across subjects depending on perfusion pressure; 4) Total 
CBV was used in Eq. (2) but actually the more relevant 
blood compartment is venous CBV [8,11].  
  Similarly, the hypercapnia-based estimation method may 
have its own potential weaknesses. Hypercapnia-based 
calculation of M is based on the assumption that CMRO2 is 
not affected by CO2 inhalation. However, this assumption 
has recently been brought into question. In a study of 
macaque monkeys under anesthesia, Zappe and colleagues 
reported that hypercapnia induced a 15% reduction in resting 
state multi-unit neural activity in the primary visual cortex 
[34]. While the authors did not measure CMRO2, it is 
possible that CMRO2 would also be altered under such 
circumstances. Several other reports done on brain slices 
provided further evidence at the cellular level that higher 
CO2 partial pressure can have a profound effect on neural 
tissue including reducing pH, elevating adenosine 
concentration, and suppressing synaptic potentials [35,36]. 
In a recently study conducted by our laboratory, we assessed 
potential effect of CO2 inhalation on CMRO2, resting state 
brain connectivity and electroencephalogram (EEG) in awa-
ke human subjects [37]. It was found that inhalation of 5% 
CO2 caused a reduction of CMRO2 by 13%. The resting state 
BOLD signal that is thought to reflect spontaneous neural 
activiatity also reduced by 20% after accounting for vascular 
differences between normo- and hypercapnia states. The 
EEG study showed that the signal power was significantly 
increased in the delta band, accompanied by a significant 
decrease in the alpha band. Therefore, the relative EEG 
power was shifted toward the lower frequency range, a 
typical pattern of reduced brain arousal state [38]. These 
evidences suggest that the M values as determined by 
hypercapnia calibration may contain bias compared to the 
true values. Interestingly, the consideration of possible 
CMRO2 reduction during hypercapnia may resolve the 
discrepancy between PET and MRI data in terms of the ratio 
of CBF and CMRO2 changes during brain activation 
[10,39,40]. 
  The lack of relationship between M and baseline venous 
oxygenation and CBF can also be discussed in terms of the 
modulator on the BOLD signal. From Eq. (1), it is clear that 
M is the modulator of BOLD signal and the greater the M is, 
the greater the BOLD signal is. Previous studies from our 
laboratory have suggested that baseline venous oxygenation 
is also a significant modulator of BOLD signal, and 
individuals with smaller venous oxygenation tend to have a 
greater BOLD signal [15]. This relationship is in line with 
the M factor effect because smaller venous oxygenation will 
result in a greater 1-Yv,0 term in Eq. (3), and a greater M. 
Baseline CBF has also been shown to be a modulator of 
BOLD signal, and individuals with smaller CBF tend to have 
a greater BOLD signal [16]. However, this effect is actually 
 
Fig. (5). Scatter plots between variables in the model for the M factor. A) Scatter plot between hypercapnia-based M and baseline venous 
oxygenation. B) Scatter plot between hypercapnia-based M and baseline CBF. C) Scatter plot between hypercapnia-based M and baseline-
parameter-estimated M. It was found that the hypercapnia-based M was not correlated with any of the variables associated with baseline 
physiology. 118    The Open Neuroimaging Journal, 2011, Volume 5  Lu et al. 
opposite to the M factor effect. That is, a smaller CBF would 
result in a smaller M factor according to Eq. (3) and should 
result in a smaller BOLD signal. Therefore, it seems that 
CBF may counteract the main effect of M. Taking into 
consideration the finding that baseline venous oxygenation 
and CBF are positively correlated (Fig. 3), we speculate that 
the influence of venous oxygenation and CBF to the M 
factor may cancel out (that is, the Yv,0 term and CBF term in 
Eq. (3) tends to offset each other), and the actual M value of 
an individual may be mostly dependent on other parameters 
such as hematocrit. It is possible that the modulation effect 
of baseline CBF on the BOLD signal is exerted through 
terms in the bracket in Eq. (1) and the venous oxygenation 
effect on BOLD is in turn through its correlation with CBF.  
CONCLUSIONS 
  Hypercapnia-calibrated M factor is not correlated with 
baseline venous oxygenation or baseline CBF across subjects 
despite their links according to the analytical expression. The 
observation of a strong correlation between venous 
oxygenation and CBF may explain the above finding 
because the influence of venous oxygenation and CBF may 
have largely cancelled out. Another possible reason is related 
to the potential errors in the hypercapnia-based M estimation 
as CMRO2 may reduce during CO2 inhalation. Further study 
is needed to elucidate the true values of M and the best 
method to accurately estimate it. 
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